A KRAS p.Q61R mutation was found in both the affected and unaffected bone of one MAP2K1 mutation-negative patient with skin lesions consistent with RASopathy, who likely has melorheostosis as part of a more complex early embryonic mosaic RASopathy, which will be reported separately. Here, MAP2K1 is linked to melorheostosis.